# Mediastinal Staging Accuracy of a Selective Lymphadenectomy Strategy in Early Stage NSCLC (ECTOP-1003)

> **NCT03216551** · — · COMPLETED · sponsor: **Fudan University** · enrollment: 1076 (actual)

## Conditions studied

- Lymph Node Metastases
- Non-small Cell Lung Cancer Stage I

## Interventions

- **DIAGNOSTIC_TEST:** Intra-operative frozen section

## Key facts

- **NCT ID:** NCT03216551
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2019-03-14
- **Primary completion:** 2022-05-30
- **Final completion:** 2022-05-30
- **Target enrollment:** 1076 (ACTUAL)
- **Last updated:** 2023-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03216551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03216551, "Mediastinal Staging Accuracy of a Selective Lymphadenectomy Strategy in Early Stage NSCLC (ECTOP-1003)". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03216551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*